Rossari Biotech (NSE:ROSSARI) Marketable Securities: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ROSSARI Rossari Biotech Ltd NSE:ROSSARI
84 GF Score
Price ₹519.95
GF Value ₹967.02
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Rossari Biotech Marketable Securities?

Rossari Biotech NSE:ROSSARI +6.16% 84 Marketable Securities is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:ROSSARI with a GF Score™ of 84/100 and a GF Value™ of ₹967.02 (Possible Value Trap). The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Rossari Biotech's Marketable Securities for the quarter that ended in Jun. 2026 was ₹0 Mil.

Rossari Biotech's annual Marketable Securities increased from Mar. 2024 (₹443 Mil) to Mar. 2025 (₹609 Mil) but then declined from Mar. 2025 (₹609 Mil) to Mar. 2026 (₹376 Mil).

Rossari Biotech  (NSE:ROSSARI) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Rossari Biotech Marketable Securities Related Terms

Rossari Biotech Marketable Securities Historical Data

* Premium members only.

The historical data trend for Rossari Biotech's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rossari Biotech Marketable Securities Chart

Rossari Biotech Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only 269.49 792.99 443.34 608.54 376.24

Rossari Biotech Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 412.91 0.00 376.24 0.00
NSE:ROSSARI
84GF Score
Rossari Biotech Ltd NSE:ROSSARI
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rossari Biotech Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹0 Mil mean?
Rossari Biotech (NSE:ROSSARI) has a Marketable Securities of ₹0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Rossari Biotech and its competitors.
Is Rossari Biotech's Marketable Securities too high?
Rossari Biotech's current Marketable Securities is ₹0 Mil. Overall, Rossari Biotech has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rossari Biotech's Marketable Securities compare to LIN and SHW?
Rossari Biotech's Marketable Securities of ₹0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Chemicals company?
A good Marketable Securities depends on the Chemicals industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Rossari Biotech and its competitors. Rossari Biotech's current Marketable Securities is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossari Biotech stock overvalued right now?
Based on GuruFocus' analysis, Rossari Biotech (NSE:ROSSARI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹967.02, compared to a current price of ₹519.95 — trading 46.2% below its estimated fair value. The current Marketable Securities is ₹0 Mil. Rossari Biotech's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Rossari Biotech (NSE:ROSSARI), the current Marketable Securities is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rossari Biotech (NSE:ROSSARI) Overvalued in 2026?

Based on GuruFocus' analysis, Rossari Biotech stock appears to be undervalued. The current stock price of ₹519.95 is trading 46.2% below its estimated GF Value™ of ₹967.02. GuruFocus considers Rossari Biotech to be Possible Value Trap.

Key valuation signals for NSE:ROSSARI:

  • Marketable Securities: ₹0 Mil
  • GF Value™: ₹967.02 vs. price of ₹519.95 (46.2% below fair value)
  • GF Score™: 84/100 with 4 warning signs

No single metric tells the full story. See the NSE:ROSSARI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rossari Biotech Business Description

Other Exchanges 543213:India
Address Rossari House, Lal Bahadur Shastri Marg, Golden Oak, Opp. Mahindra Showroom, Vikhroli (West), Surya Nagar, Mumbai, MH, IND, 400079
Rossari Biotech Ltd is a specialty chemical manufacturing company. It provides customized solutions to specific industrial and production requirements of its customers in the FMCG, apparel, poultry, and animal feed industries through its product portfolio comprising home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its business is organized into three categories: home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its products include soaps and detergents, paints, inks and coatings, ceramics and tiles, water treatment chemicals, pulp and paper, and cleaning chemical formulations, among others. The company generates the majority revenue from India.
84GF Score

Get the complete analysis for NSE:ROSSARI

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹519.95
Price
₹967.02
GF Value